Catalyst Pharma files lawsuit against FDA approval of Jacobus Pharma's drug
Catalyst Pharmaceuticals Inc said on Wednesday it has filed a lawsuit against the U.S. Food and Drug Administration, challenging the recent approval of Jacobus Pharmaceutical Co's drug, Ruzurgi, for a rare neuromuscular disease.
from Reuters: Health News https://reut.rs/2Zo9NCX
http://bit.ly/2zwRqiM